有趣的是，Infigratinib最初于2021年获批用于胆管癌，后因适应症开发策略调整而主动撤回。如今，其有望在ACH赛道迎来“第二春”。基于其疗效和口服便利性，BridgeBio在今年的JPM大会上预测，该药Infigratinib将占据ACH治疗市场50%以上的份额。
19:50, 27 февраля 2026Из жизни
，详情可参考Line官方版本下载
if urlparse(full_url).netloc == urlparse(self.base_url).netloc:
To test this, we can start a VM with qemu:
According to a study commissioned by Reddit and marketing intelligence company Profound, Reddit was found to be the number one most cited source across AI platforms such as Google AI Overviews and Perplexity.